Clinical Trial Center of the Charité Comprehensive Cancer Center
Clinical trials are a very important instrument for the continuous development of diagnostics and therapy as well as quality of care.
The Charité Comprehensive Cancer Center (CCCC) coordinates the numerous clinical tumor trials at Charité - Universitätsmedizin Berlin.
You are here:
The Clinical Trial Unit (CTU) of the CCCC provides assistance with regard to the development of new investigator initiated trials (IITs) and request for authorisation to the competent authorities within the different Organ Tumor Centers of the CCCC. An additional objective of the CTU is to achieve harmonization of all studies conducted at the CCCC in close cooperation with the trial coordinators of the various Organ Tumor Groups of the Center and to stimulate an increased participation in important national or international trials. In doing so, the CCCC works also closely with the European Organisation for Research and Treatment of Cancer (EORTC).
Information on Clinical Trials
Before a clinical trial starts at Charité in accordance with the German Medicinal Products Act, it must be reviewed and approved by the Ethics Committee of the State Office for Health and Social Affairs (LaGeSo) and by the responsible higher federal and state authorities.
In the case of a clinical trial, in addition to these approval procedures, the suitability of each individual trial site must be reviewed by the state ethics committee. Only then can a clinical trial begin.
Here you can find information at any time about all clinical trials, each of which is active for a specific cancer disease. The Cancer Hotline is also available for your inquiries.